AgoneX Biopharmaceuticals

Faced with increasing competition, banking and financial services organizations must move quickly to meet new customer, employee and industry demands while addressing complex regulatory mandates and heightened security threats.

The company offers help with technology problems.

The company provides 24/7 maintenance and monitoring for computers, servers, and systems.

Davis Global Logistics offers customized transportation and logistics solutions and moves, manages, and distributes commercial and retail goods across Metro Detroit.

Free 30 Day Trial. No credit card required. Cancel anytime.

The page introduces the board of advisors at AgoneX Biopharmaceuticals Inc.

The page introduces the board of directors at AgoneX Biopharmaceuticals Inc.

The Honorable Richard A. Gephardt Chairman, Board of Directors

The page introduces team members at AgoneX Biopharmaceuticals Inc.

The company says it builds on its technologies, competencies, and customer interests and focuses on clients’ emerging needs and business and technological change.

Davis Global says its team listens to customers’ challenges, needs, and goals to provide transportation solutions.

2307 Beverley Rd Brooklyn, New York 11226 United States.

The National Headache Foundation estimates that headaches cost U.S. businesses $50 billion annually; a 2001 report cited more than 30 million U.S. migraine sufferers and ranked migraine the country’s 12th most disabling disorder.

AgoneX Biopharmaceuticals, Inc. is a Delaware clinical-stage molecular nanotechnology biopharmaceutical company.

NanoSoft is a privately owned IT support and services business formed in 1988; its team of IT engineers addresses technology problems and business needs.

A research report names Orphazyme ApS, ApoPharma Inc., and BioHealthonomics Inc. among key players in the amyotrophic lateral sclerosis (ALS) therapeutic pipeline market.

May 2017 · RnRMarketResearch (via PR Newswire)News article

The review reports that BioHealthonomics Inc. filed an investigational new drug application for migraine prophylaxis in December 2013. It also mentions enrollment in a Phase 2 trial, without providing further trial details.

Dec 2015 · HeadacheNews article

BioHealthonomics Inc. filed its first investigational new drug application for migraine prophylaxis in December 2013. The filing is noted in a clinical-trials review covering 2014.

Dec 2014 · HeadacheNews article